| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,3 M € | +12.2% | 2,0 M € | +19.8% | 1,7 M € | +303.6% | 418,3 k € | -1.5% | 424,8 k € | -17.0% | 511,6 k € | -49.0% | 1,0 M € | -13.8% | 1,2 M € | -13.9% | 1,4 M € | -38.2% | 2,2 M € | +18.7% | 1,8 M € | +20.8% | 1,5 M € | -1.0% | 1,5 M € | -3.9% | 1,6 M € | -6.5% | 1,7 M € | -23.2% | 2,2 M € | -33.8% | 3,4 M € | |
| EBITDA | 1,2 M € | +405.9% | 246,0 k € | +84.8% | 133,1 k € | +235.9% | 39,6 k € | +22.8% | 32,3 k € | +35.7% | 23,8 k € | +107.8% | -305,3 k € | -819.6% | 42,4 k € | -26.2% | 57,5 k € | +5.4% | 54,5 k € | -56.5% | 125,3 k € | -80.2% | 634,5 k € | +282.9% | 165,7 k € | +47.4% | 112,4 k € | +149.6% | -226,8 k € | -31.3% | -172,8 k € | +13.9% | -200,7 k € | |
| Operating profit | 1,2 M € | +458.3% | 219,2 k € | +151.0% | 87,3 k € | +391.0% | 17,8 k € | -37.7% | 28,6 k € | +13.7% | 25,1 k € | +108.5% | -294,1 k € | -711.3% | 48,1 k € | -2.5% | 49,3 k € | -18.4% | 60,4 k € | -52.7% | 127,6 k € | -79.3% | 616,0 k € | +284.8% | 160,1 k € | +45.9% | 109,7 k € | +145.8% | -239,6 k € | -30.1% | -184,2 k € | -380.0% | -38,4 k € | |
| Profit/loss | 985,1 k € | +568.3% | 147,4 k € | +123.3% | 66,0 k € | -95.9% | 1,6 M € | +7359.1% | 21,7 k € | +10.5% | 19,7 k € | +106.7% | -295,7 k € | -1478.4% | 21,5 k € | +46.7% | 14,6 k € | +13.1% | 12,9 k € | -74.0% | 49,8 k € | -89.6% | 480,0 k € | +620.2% | 66,6 k € | -13.3% | 76,8 k € | +131.3% | -245,6 k € | +51.3% | -504,5 k € | -617.6% | 97,5 k € | |
| Equity | 2,4 M € | +71.0% | 1,4 M € | +11.9% | 1,2 M € | +5.6% | 1,2 M € | +1307.0% | -97,3 k € | +18.3% | -119,0 k € | +14.2% | -138,7 k € | -188.3% | 157,0 k € | +15.8% | 135,6 k € | -33.3% | 203,1 k € | +6.8% | 190,2 k € | +35.5% | 140,3 k € | +141.3% | -339,6 k € | +16.4% | -406,3 k € | +15.9% | -483,1 k € | -103.4% | -237,5 k € | -189.0% | 267,0 k € | |
| Total assets | 3,6 M € | +43.2% | 2,5 M € | +36.5% | 1,8 M € | +6.2% | 1,7 M € | +557.6% | 260,9 k € | -54.3% | 570,3 k € | +151.1% | 227,1 k € | -78.5% | 1,1 M € | +153.6% | 415,8 k € | -79.2% | 2,0 M € | -7.6% | 2,2 M € | +16.5% | 1,9 M € | +69.5% | 1,1 M € | +25.9% | 868,4 k € | +35.7% | 639,7 k € | -57.0% | 1,5 M € | -6.3% | 1,6 M € | |
| Cash | 188,9 k € | +25.1% | 151,0 k € | -83.5% | 913,9 k € | -39.5% | 1,5 M € | — | 0,0 € | -50.0% | 0,0 € | 0.0% | 0,0 € | — | 64,8 k € | -93.6% | 1,0 M € | -3.0% | 1,0 M € | +354.1% | 228,7 k € | +2033.3% | 10,7 k € | -81.9% | 59,1 k € | +19.0% | 49,7 k € | -32.1% | 73,2 k € | |||||
| Debts | 1,1 M € | +14.3% | 996,2 k € | +114.4% | 464,7 k € | +5.6% | 440,2 k € | +59.2% | 276,4 k € | -51.2% | 566,0 k € | +112.2% | 266,7 k € | -67.6% | 822,2 k € | +316.8% | 197,3 k € | -87.8% | 1,6 M € | +4.9% | 1,5 M € | +13.3% | 1,4 M € | +28.4% | 1,1 M € | +17.1% | 904,8 k € | +5.5% | 857,3 k € | -29.4% | 1,2 M € | +9.9% | 1,1 M € | |
| Staff | 4,1 | 5,9 | 7,2 | 3 | 2,9 | 3,8 | 5,3 | 7,8 | 7,6 | 7,2 | 7,2 | 6 | 6,4 | 4,9 | 6,1 | 8 | 6,6 | |||||||||||||||||
Public limited company · Aarschot · incorporated on 12/06/1989 · 4,1 ETP
Public limited company profitable and well capitalised. Cash position rising (+25.1%).
Solid counterparty for a standard engagement.
ZimVie Belgium is a Public limited company incorporated in 1989. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Aarschot. It employs on average 4,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette